Torrey Pines Investment

Torrey Pines Investment is a San Diego-based specialty life-science investment firm established in 2012. The firm specializes in supporting biopharma and diagnostics accelerators by investing in early development stage assets from pharmaceutical and biotech partners in areas such as central nervous system (CNS) disorders, oncology, and virology. Their goal is to bring these assets to success through pharmaceutical partnerships and mergers and acquisitions.

The firm's investment strategy involves leveraging a team of professionals with extensive experience in entrepreneurship, venture capital, and operations. Torrey Pines Investment assists its portfolio companies with both product and corporate development by utilizing expertise in drug discovery, including non-clinical and clinical studies, manufacturing and quality, as well as regulatory affairs.

Notable companies in Torrey Pines Investment's portfolio include Viriom Inc., Avelas Biosciences, and Chromis Therapeutics. These companies are dedicated to advancing groundbreaking treatments for various health challenges, such as HIV, chronic hepatitis B, and respiratory infections. The firm continues to seek innovative opportunities to support the growth and success of life-science ventures.